All Stories

  1. The Reducer device in patients with angina pectoris: mechanisms, indications, and perspectives
  2. Targeted anti-inflammatory systemic therapy for restenosis: The Biorest Liposomal Alendronate with Stenting sTudy (BLAST)—a double blind, randomized clinical trial